Ten million deaths only in 2024

Full article

the risks of cancer, its prevention and innovative treatments

Cancer in the 21st Century: Advances, Challenges, and Perspectives

Introduction

Cancer is one of the major diseases of the 21st century and, without doubt, one of the greatest health, social, and economic challenges worldwide. Although it represents a diverse set of conditions—over 200 different types—all share a common mechanism: uncontrolled cell growth that escapes the body’s natural regulatory systems. The impact is enormous. According to the World Health Organization, in 2020 nearly 19 million new cases were diagnosed and 10 million cancer-related deaths were recorded globally. These figures are expected to increase, driven by population aging, exposure to risk factors, and persistent inequalities in prevention and treatment.

Risk Factors and Prevention

Cancer in the 21st century reflects the interaction between genetic predisposition and environmental exposure. Tobacco remains the leading preventable cause, responsible for about one-third of related deaths. Alcohol consumption, obesity, physical inactivity, poor diet, and exposure to carcinogens are also significant contributors. Climate change and air pollution are increasingly recognized as relevant factors. Prevention, therefore, is central. Vaccination campaigns against human papillomavirus (HPV) and hepatitis B have significantly reduced cervical cancer and hepatocellular carcinoma incidence, respectively. Screening programs such as mammography, colonoscopy, and fecal occult blood tests have enabled earlier diagnoses and, as a result, better prognoses.

Advances in Diagnosis

The 21st century has witnessed a technological revolution in cancer diagnosis. Genomic sequencing has made it possible to identify specific mutations and classify tumors not only by anatomical site but also by molecular profile. This has paved the way for precision medicine. Imaging techniques have also advanced, including positron emission tomography (PET), functional magnetic resonance imaging, and artificial intelligence applied to radiological interpretation, allowing earlier detection and better characterization of tumors. Another remarkable advance is the liquid biopsy, which identifies circulating tumor cells or DNA fragments in blood, offering minimally invasive, dynamic insights into disease progression.

Innovative Treatments

Therapeutic approaches have changed radically. Surgery and radiotherapy remain fundamental pillars, but traditional chemotherapy has ceded ground to new treatments. Targeted therapies block specific molecules responsible for tumor growth, while immunotherapy stimulates the immune system to recognize and destroy cancer cells. Immune checkpoint inhibitors (such as PD-1/PD-L1 and CTLA-4 inhibitors) have revolutionized treatment, achieving long-term survival in cancers once deemed untreatable, like metastatic melanoma and certain lung cancers. CAR-T cell therapies, although still in early phases and facing challenges of cost and logistics, offer tangible hope for hematological malignancies.

Current Challenges

Despite progress, cancer remains marked by deep inequalities. Access to innovative treatments varies widely between countries and even within regions. The high cost of advanced therapies raises questions about sustainability for health systems. Beyond medical care, the emotional, social, and financial impact on patients and families remains enormous. The need for quality palliative care and comprehensive approaches that include mental health is increasingly recognized. Scientific challenges also persist: tumor resistance to treatment, the heterogeneity of tumors, and the adaptability of cancer cells all complicate effective control.

The Future of Cancer in the 21st Century

The outlook is promising. Integration of artificial intelligence and big data in biomedical research will help identify patterns previously invisible and further personalize treatment. Gene therapy and genetic editing tools such as CRISPR open unprecedented possibilities for correcting mutations responsible for certain cancers. At the same time, awareness is growing that defeating cancer is not only a laboratory challenge but a societal one. Promoting healthy lifestyles, reducing exposure to pollutants, and ensuring equitable access to care are essential pillars. Cancer in the 21st century should not be seen solely as a threat but as an opportunity to mobilize the best of science, technology, and human cooperation. If medical advances are matched by firm social and political commitment, it is possible to imagine a future where cancer is no longer a death sentence but a preventable, treatable, and in many cases, curable condition.